FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann/File Photo
ZURICH (Reuters) – Swiss drugmaker Roche said on Friday it will start selling a new digital diagnostics product that may simplify and accelerate screening of patients with breathing problems during the COVID-19 pandemic.
Roche’s v-TAC, a new digital diagnostic solution that could help clinicians get faster results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a puncture in a vein, is available in markets that accept the CE mark, the company said.
Reporting by John Miller; Editing by Riham Alkousaa
Our Standards:The Thomson Reuters Trust Principles.